Brian Napack Joins Siensmetrica Advisory Board to Enhance Tessa's Impact on Research Evaluation

Siensmetrica Welcomes Brian Napack to Advisory Board

Siensmetrica, Inc., renowned for its innovative AI-driven research analysis platform, Tessa, has officially announced the appointment of Brian Napack to its advisory board. This strategic move aims to harness Napack’s extensive experience at the intersection of science, education, and technology. With decades of executive leadership under his belt, Napack’s influence is anticipated to enhance the ongoing development and scalability of Tessa.

A Legacy of Leadership

Brian Napack is not a stranger to the realms of education, scientific research, and information services. Before joining Siensmetrica, he held significant roles including the CEO of John Wiley & Sons, a leading global research and education publisher. His tenure at Wiley positioned him at the forefront of technology-enabled services aimed at making education and scientific inquiry more efficient. Napack's active role extends beyond executive positions; he serves as Executive Chairman at 2U and holds director positions at RB Media and Elentra.

His impressive credentials include leadership roles at Macmillan as President and Chairman of the Association of American Publishers. Moreover, his broad spectrum of experience as a Senior Advisor at Providence Equity and a Partner at L.E.K. Consulting, contributes to his unique perspective on media and education. Notably, Napack was instrumental in founding Disney Educational Publishing and played pivotal roles in Disney Interactive, showcasing his commitment to educational innovation.

A Strategic Fit for Tessa

Marc Toth, CEO of Siensmetrica, highlighted the significance of Napack's appointment by noting, "Brian’s background reaches nearly every corner of how research and knowledge get published, evaluated, and trusted." This highlights not merely an addition to the advisory board but a move that aligns strategically with Siensmetrica's mission to improve transparency in biomedical research evaluation through Tessa. Tessa is designed to analyze scientific literature across almost 200 methodological and contextual data points, generating standardized metrics indicative of trustworthiness (TScores) and facilitating deep analytical assessments.

In a world where the volume of published research grows exponentially, the challenge remains how to distill this information effectively. Tessa addresses this challenge by enabling users—including researchers, clinicians, policymakers, and leaders in biopharma—to differentiate between high-quality and flawed evidence swiftly.

Looking Ahead

Napack himself expressed enthusiasm about joining an organization that is at the forefront of delivering innovative solutions: "The accelerating pace of scientific discovery presents a huge opportunity to advance human progress, but it also presents a major challenge for research-intensive industries. Tessa is accelerating innovation, allowing users to sort through research findings efficiently, and I am thrilled to collaborate with this team to enhance our methods of evaluating scientific material."

Siensmetrica is dedicated to assisting medical and scientific professionals in delivering superior care and accelerating breakthroughs. By harnessing Tessa’s proprietary evaluation framework known as Transparency, Explainability, and Significance (T.E.S.), the company aims to produce clear objective scores and detailed analyses of biomedical literature.

As Siensmetrica continues to expand Tessa's reach and capabilities, the inclusion of Brian Napack on the advisory board is poised to have considerable influence. His wealth of knowledge and proven track record in education and research sectors will undoubtedly aid in steering the company's technology to better serve those who rely on trustworthy scientific insights.